Covestor’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
CM
Covestor's ANIK Position: Q3 2026 in Review
Covestor held its Anika Therapeutics (ANIK) position steady in Q3 2026 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2316.
Covestor first reported a position in ANIK in Q3 2022 and has held it in 16 quarters since. The position peaked at $3K in Q3 2022. 97 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.
- Covestor held 13 shares of Anika Therapeutics worth $0 as of Q3 2026.
- Covestor left its Anika Therapeutics share count unchanged in Q3 2026.
- Anika Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2316 holding.
- Covestor first reported a position in Anika Therapeutics in Q3 2022 and has held it in 16 quarters since.
- Covestor's Anika Therapeutics position peaked at $3K in Q3 2022.
- 97 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.